Summary
The disappearance of a drug induced SLE syndrome in a 43 year old man, was described. He replaced antihypertensive agent hydralazine by an other vasodilatating agent cadralazine.
This is a preview of subscription content, log in via an institution to check access.
References
Catalano M, Parini J, Romano M, Libretti A (1955) Controlled clinical trial of cadralazine as a second step drug in the treatment of hypertension. Eur J Clin Pharmacol 28: 135–135
Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J 289: 410–412
Cush JJ, Goldings EA (1985) Drug induced lupus: clinical spectrum and pathogenesis. Am J Med Sci 290: 36–45
Andersson OK (1987) Cadralazine did not produce the SLE-syndrom when hydralazine did. Eur J Clin Pharmacol 31: 741
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mulder, H. Conversion of drug-induced SLE-syndrome by the vasodilating agent cadralazine. Eur J Clin Pharmacol 38, 303 (1990). https://doi.org/10.1007/BF00315036
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315036